World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
28681
World Ranking
14082
National Ranking
7145

Susan L. Cohn publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Susan L. Cohn sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 336 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Susan L. Cohn D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Susan L. Cohn sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Susan L. Cohn is affiliated with the University of Chicago in the United States. Their research career focuses extensively on medicine, with significant contributions in biochemistry, genetics, and molecular biology. Within these broader fields, their work is particularly concentrated in subfields such as neurology, cancer research, pediatrics, perinatology and child health, molecular biology, and oncology.

Their research primarily addresses topics including neuroblastoma research and treatments, cancer, hypoxia, and metabolism, cancer therapeutics and mechanisms, the quality of life of childhood cancer survivors, neurofibromatosis and schwannoma cases, glioma diagnosis and treatment, as well as lung cancer research studies.

Susan L. Cohn has published numerous papers in several prominent scientific venues. Frequent publication venues of their work include:

  • Journal of Clinical Oncology
  • Pediatric Blood & Cancer
  • JCO Clinical Cancer Informatics
  • Clinical Cancer Research
  • Cancer

Their recent papers highlight research on neuroblastoma and related therapies. Notable publications include:

  • "Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group" (2021, Journal of Clinical Oncology)
  • "Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032" (2021, Clinical Cancer Research)
  • "Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium" (2021, Journal of Clinical Oncology)
  • "Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project" (2020, Journal of Clinical Oncology)
  • "Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future" (2020, JCO Clinical Cancer Informatics)

Frequent collaborators include several researchers with whom Susan L. Cohn has coauthored multiple publications. These coauthors are:

  • Arlene Naranjo
  • Wendy B. London
  • Julie R. Park
  • Mark A. Applebaum
  • Ami V. Desai

Best Publications

  • Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

    Alice L. Yu;Andrew L. Gilman;M. Fevzi Ozkaynak;Wendy B. London

  • The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

    Susan L. Cohn;Andrew D.J. Pearson;Wendy B. London;Tom Monclair

  • The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report

    Tom Monclair;Garrett M. Brodeur;Peter F. Ambros;Hervé J. Brisse

  • Advances in Risk Classification and Treatment Strategies for Neuroblastoma

    Navin R. Pinto;Mark A. Applebaum;Samuel L. Volchenboum;Katherine K. Matthay

  • Chromosome 1p and 11q deletions and outcome in neuroblastoma.

    Edward F. Attiyeh;Wendy B. London;Yael P. Mossé;Qun Wang

  • Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

    W.B. London;R.P. Castleberry;K.K. Matthay;A.T. Look

  • Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project

    Hervé J. Brisse;M. Beth McCarville;Claudio Granata;K. Barbara Krug

  • Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma.

    Dafna Meitar;Susan E. Crawford;Alfred W. Rademaker;Susan L. Cohn

  • International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

    PF Ambros;IM Ambros;GM Brodeur;M Haber

  • Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma

    Murray D. Norris;Sharon B. Bordow;Glenn M. Marshall;Paul S. Haber

  • Children's Oncology Group's 2013 blueprint for research: Neuroblastoma

    Julie R. Park;Rochelle Bagatell;Wendy B. London;John M. Maris

  • Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma

    David L. Baker;Mary L. Schmidt;Susan L. Cohn;John M. Maris

  • Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study

    Suzanne S. Shusterman;Wendy B. London;Stephen D. Gillies;Jacquelyn A. Hank

  • Advances in the diagnosis and treatment of neuroblastoma

    Joanna L. Weinstein;Howard M. Katzenstein;Susan L. Cohn

  • Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

    Wendy B. London;Victoria Castel;Tom Monclair;Peter F. Ambros

  • Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

    Susan G Kreissman;Robert C Seeger;Katherine K Matthay;Wendy B London;Wendy B London

  • Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial.

    Julie R. Park;Julie R. Park;Susan G. Kreissman;Wendy B. London;Arlene Naranjo

  • Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.

    Meredith S Irwin;Arlene Naranjo;Fan F Zhang;Susan L Cohn

  • Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial

    Birgit Geoerger;Hyoung Jin Kang;Michal Yalon-Oren;Lynley V Marshall

  • Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.

    Julie R Park;Rochelle Bagatell;Susan L Cohn;Andrew D Pearson

Frequent Co-Authors

Wendy B. London
Wendy B. London Harvard University
John M. Maris
John M. Maris Children's Hospital of Philadelphia
Katherine K. Matthay
Katherine K. Matthay University of California, San Francisco
Garrett M. Brodeur
Garrett M. Brodeur Children's Hospital of Philadelphia
Andrew D.J. Pearson
Andrew D.J. Pearson Royal Marsden NHS Foundation Trust
Hiroyuki Shimada
Hiroyuki Shimada Stanford University
Michael D. Hogarty
Michael D. Hogarty Children's Hospital of Philadelphia
Peter F. Ambros
Peter F. Ambros St Anna Children's Hospital
Robert C. Seeger
Robert C. Seeger Children's Hospital of Los Angeles
A. Thomas Look
A. Thomas Look Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine isn't limited to becoming a doctor. There are numerous online degrees and pathways offering flexibility and affordability for aspiring healthcare professionals. For registered nurses seeking to advance their qualifications, consider enrolling in the cheapest rn to bsn program online to complete your Bachelor of Science in Nursing at a reduced cost.

Those with a non-nursing background but interested in nursing can look into direct entry msn programs for non-nursing majors online. These programs enable career changers to enter the nursing field with an accelerated master’s degree.

Applicants who are concerned about competitive admissions may benefit from reviewing nursing programs with high acceptance rates, which provide more accessible entry points to starting a nursing career.

Beyond direct patient care, prospective students can also enter the healthcare industry through administrative roles. Accredited online options, like accredited medical billing and coding schools online with financial aid, offer an affordable way to qualify for essential positions in medical records and billing.

Best Scientists Citing Susan L. Cohn

Trending Scientists

Recently Published Articles